Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01193166

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

A Twelve-Month, Prospective, Randomized, Active-Controlled, Open-Label, Flexible-Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 12 months, in patients diagnosed with schizophrenia who were recently released from an inpatient psychiatric hospital.

Detailed description

The primary objective of this study will be to compare paliperidone palmitate treatment with the randomly assigned oral antipsychotic treatment in delaying time to treatment failure over 12 months in subjects diagnosed with schizophrenia who were recently discharged from an inpatient psychiatric hospital. Patients will receive either paliperidone palmitate 78, 117, 156, or 234 mg monthly by injection for twelve months OR oral aripiprazole, haloperidol, olanzapine, paliperidone, perphenazine, quetiapine, and risperidone at doses selected by the study doctor.

Conditions

Interventions

TypeNameDescription
DRUGpaliperidone palmitate78, 117, 156, or 234 mg monthly injection for 12 months
DRUGrisperidoneflexible dosing as prescribed by the study doctor for 12 months
DRUGolanzapineflexible dosing as prescribed by the study doctor for 12 months
DRUGaripiprazoleflexible dosing as prescribed by the study doctor for 12 months
DRUGhaloperidoleflexible dosing as prescribed by the study doctor for 12 months
DRUGquetiapineflexible dosing as prescribed by the study doctor for 12 months
DRUGperphenazineflexible dosing as prescribed by the study doctor for 12 months
DRUGpaliperidoneflexible dosing as prescribed by the study doctor for 12 months

Timeline

Start date
2010-08-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2010-09-01
Last updated
2013-07-08

Source: ClinicalTrials.gov record NCT01193166. Inclusion in this directory is not an endorsement.